BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9593287)

  • 41. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies.
    Hilden JM; Kersey JH
    Leuk Lymphoma; 1994 Jul; 14(3-4):189-95. PubMed ID: 7950907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MLL translocations with concurrent 3' deletions: interpretation of FISH results.
    Barber KE; Ford AM; Harris RL; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2004 Nov; 41(3):266-71. PubMed ID: 15334550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Segmental amplification of 11q23 region identified by fluorescence in situ hybridization in four patients with myeloid disorders: a review.
    Reddy KS; Parsons L; Mak L; Dighe P; Saphner T; Crow MK; Scott M
    Cancer Genet Cytogenet; 2001 Apr; 126(2):139-46. PubMed ID: 11376807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
    Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements.
    Johansson B; Fioretos T; Kullendorff CM; Wiebe T; Békássy AN; Garwicz S; Forestier E; Roos G; Akerman M; Mitelman F; Billström R
    Genes Chromosomes Cancer; 2000 Feb; 27(2):136-42. PubMed ID: 10612801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study on 289 consecutive Korean patients with acute leukaemias revealed fluorescence in situ hybridization detects the MLL translocation without cytogenetic evidence both initially and during follow-up.
    Kim HJ; Cho HI; Kim EC; Ko EK; See CJ; Park SY; Lee DS
    Br J Haematol; 2002 Dec; 119(4):930-9. PubMed ID: 12472570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
    J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
    Bernstein SH; Brunetto VL; Davey FR; Wurster-Hill D; Mayer RJ; Stone RM; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1996 Sep; 14(9):2486-94. PubMed ID: 8823327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combination of interphase- and metaphase-fluorescence in situ hybridization to identify 11q23/MLL abnormalities in acute leukemia patients].
    Zhao XC; Li CW; Dai Y; Liu XP; Qin S; Liu SH; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):682-6. PubMed ID: 17343201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion.
    Matsuda K; Hidaka E; Ishida F; Yamauchi K; Makishima H; Ito T; Suzuki T; Imagawa E; Sano K; Katsuyama T; Ota H
    Cancer Genet Cytogenet; 2006 Nov; 171(1):24-30. PubMed ID: 17074587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
    Guo Y; Xue Y; Xie X; Wu D; Li J; Lu D; Jiang F; Geng M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):72-5. PubMed ID: 10751523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia.
    Mathew S; Head D; Rubnitz JE; Raimondi SC
    Genes Chromosomes Cancer; 2000 Jun; 28(2):227-32. PubMed ID: 10825008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on mixed lineage leukemia gene rearrangement in AML-M4/M5 by interphase fluorescence in situ hybridization].
    Pan JL; Xue YQ; Jiang HY; Li JY; Chen SN; Wu YF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):288-90. PubMed ID: 15192841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
    Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
    Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features.
    Wang SA; Abruzzo LV; Hasserjian RP; Zhang L; Hu Y; Zhang Y; Zhao M; Galili N; Raza A; Medeiros LJ; Garcia-Manero G; Miranda RN
    Leuk Res; 2011 Mar; 35(3):351-7. PubMed ID: 20691474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Rearrangements of chromosome 9 in different hematological neoplasia].
    Andreeva SV; Drozdova VD; Ponochevnaia EV; Kavardakova NV
    Tsitol Genet; 2008; 42(5):72-9. PubMed ID: 19140443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.